Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma

Ji Hyun Lee, Sung‐Hyun Kim, Hye Ryeon Kim, Chang‐Ki Min, Je‐Jung Lee, Ho‐Jin Shin, Jae‐Cheol Jo, Ji Yun Lee, Joon Ho Moon, Kihyun Kım